BT Group H1 Pre-tax Income Falls, But Revenue Rises

BT Group Plc (BT), a British telecommunications firm, on Thursday posted a decline in pre-tax earnings for the first-half, that reflected increased depreciation from network build and higher specific costs.

However, the company's revenue moved up due to growth in Consumer and Openreach divisions.

For the first-half to September 30, the UK-based company posted a pre-tax income of 831 million pounds, compared with 1.009 billion pounds a year ago.

Post-tax earnings were at 893 million pounds or 9.1 pence per basic share, higher than last year's 431 million pounds or 4.4 pence per share, posted for the same period of 2021.

Excluding items, basic earnings per share fell to 10 pence from 10.2 pence per share, posted for the first-half of 2021.

Adjusted EBITDA stood at 3.873 billion pounds as against 3.748 billion pounds a year ago.

Consumer division generated adjusted revenues of 4.992 billion pounds, versus 4.857 billion pounds of previous year.

Adjusted revenue from Openreach division was at 2.836 billion pounds, higher than 2.707 billion pounds, posted for the first-half of 2021.

The Group reported total revenue of 10.366 billion pounds, higher than 10.305 billion pounds, a year ago.

BT Group has declared an interim dividend of 2.31 pence per share, unchanged from last year's 2.31 pence per share.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Consumer Product Safety Commission or CPSC announced recall of thousands of children's Robes made in China and sold exclusively on Amazon.com by various companies. The recalled robes fail to meet the federal flammability standards for children's sleepwear, posing a risk of burn injuries to children. Further, citing the same concerns, Paper Cape children's pajamas manufactured in Peru ... Health services company Cigna Corp. reported Friday higher profit in its fourth quarter reflecting growth in both Evernorth and Cigna Healthcare segments. Adjusted earnings and topline beat market estimates. Looking ahead for fiscal 2023, the company projects adjusted earnings and adjusted revenues to be higher than last year, but below market view. French drug major Sanofi SA reported Friday higher profit in its fourth quarter with strong revenue growth mainly with strong sales of Dupixent. Looking ahead for fiscal 2023, the company projects higher business earnings, but the expected growth is slower than recorded in fiscal 2022. Sanofi shares were losing around 4 percent in the morning trading in Paris as well as in pre-market activity...
Follow RTT